Genmab A/S (GMAB)
Nasdaq: GMAB · Pharmaceutical Preparations · 1253 Copenhagen K, DK · filing with the SEC since 2008
Who owns Genmab A/S
As filed with the SECHolders of 5% or more
3
Darwin Global Management, Ltd. holds 5.9% of Ordinary Shares, nominal value DKK 1 per share, as its SCHEDULE 13G filed Oct 5, 2026 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Darwin Global Management, Ltd.
SCHEDULE 13G · filed Oct 5, 2026 · Ordinary Shares, nominal value DKK 1 per share
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock
Orbis Investment Management Ltd
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares and American Depositary Shares (ADS), each 10 ADS representing 1 Ordinary Share · 5.5% in May 15, 2026
What GMAB reports owning in othersstakes of 5% or more, and other ties
Merus N.V.
SCHEDULE 13D/A · filed Dec 30, 2025 · Common Shares, Euro 0.09 nominal value per share · reported falling below 5%
Other ties the annual report names
Profoundbio
A company bought · acquisition · owns, named in the 20-F filed Feb 17, 2026
7 subsidiaries in 1 country, from the list filed with the 20-F filed Feb 17, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.